TVTX

As of 2026-10-26, TVTX scores 37out of 100 on QNTM’s five-factor quantitative model, a low conviction reading. The score blends momentum, quality, volume, value and sentiment, then adjusts for the current macro regime. TVTX trades at $49.97, 34% below the band floor.

TVTX scores 37 out of 100 on QNTM's five-factor model — a low-conviction reading — at 37 the factor profile is among the weaker names in the universe. Its strongest factor is value at 58 (solid), where it screens cheap on the model's valuation inputs, followed by volume at 47. The weakest is sentiment at 20, where sentiment signals are working against it. Among Healthcare stocks it sits in the lower 12% of Healthcare names by composite.

On valuation, TVTX is priced near the floor of its own recent range — the cheap end on the model's valuation read. The blended composite before the macro overlay was 38. Same-sector names the model rates nearby include HALO, VEEV, THC.

This is a descriptive factor read on TVTX, recomputed each trading day and shown with its reasoning — not a recommendation to buy, hold or sell. The score reflects where TVTX sits on the model's measures today, and can change as new data arrives.

FACTOR BREAKDOWN

VALUATION RANGE

QNTM’s descriptive fair-value band for TVTX runs $75.66–$116.74. Current price $49.97 sits 34% below the band floor. This is valuation context, not a price target.

OTHER HEALTHCARE NAMES

QNTM provides quantitative model outputs for informational and educational purposes only. It is not investment advice and QNTM is not a registered investment adviser. Scores are rankings, not buy/sell recommendations. Data as of 2026-10-26.